Cipher Pharmaceuticals (TSX: CPH) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $0.19 by 26.32 percent. This is a 140 percent increase over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $12.505 million which missed the analyst consensus estimate of $16.746 million by 25.32 percent. This is a 4.04 percent increase over sales of $12.019 million the same period last year.